deficiency in rodents results in impaired fertility, low sperm counts and a low number of motile spermatozoa. We investigated the role of activated VD (1,25(OH) 2 D 3 ) in human spermatozoa and whether VD serum levels are associated with semen quality.
Introduction
The vitamin D receptor (VDR) and the vitamin D (VD) metabolizing enzymes are expressed in the human ejaculatory duct, germ cells and mature spermatozoa (Blomberg Jensen et al., 2010) . The importance of VD for male reproduction has been demonstrated in several animal studies (Inpanbutr et al., 1996; Kinuta et al., 2000; Bouillon et al., 2008) . One of the VDR knockout mice models is characterized by an infertile phenotype (Kinuta et al., 2000; Bouillon et al., 2008) , and VD deficiency in rodents leads to reduced sperm counts, impaired sperm motility and lower fertility rates in females inseminated with semen from VD deficient males (Kwiecinski et al., 1989) . In humans, VDR and all the VD metabolizing enzymes are co-expressed during the late stages of spermatogenesis in the neck of mature spermatozoa (Nangia et al., 2007; Blomberg Jensen et al., 2010) . Optimal sperm function may thus depend on a direct effect of VD; however, it could also be influenced indirectly through calcium homeostasis since the impaired fertility in animal models was partly restored solely by normalization of serum calcium levels (Uhland et al., 1992) . VD has widespread biological functions, including an essential role for systemic calcium homeostasis (Bouillon et al., 2008) and a role for calcium in the maturation of human spermatozoa is well documented and highlighted by the 2 -3-fold higher calcium concentration in human epididymal and prostate fluid compared with serum. VD has been hypothesized to be important for the proposed trans-epithelial calcium transfer in the epididymis (Blomberg Jensen et al., 2010) .
The effects of VD rely on activation of cholecalciferol (inactive vitamin D 3 ), which normally starts in the skin, where UV-B irradiation converts 7-hydrocholesterol to VD 3 . It is subsequently activated by the hepatic 25-hydroxylases (CYP2R1, CYP27A1) and the renal 1a-hydroxylase (CYP27B1), before the active 1,25(OH) 2 D 3 (calcitriol) binds with high affinity to the VDR until inactivated by CYP24A1 (Prosser and Jones, 2004) . 1,25(OH) 2 D 3 exerts both genomic and non-genomic actions through binding to VDR (Norman, 1998) , but the precise effects of VD in human spermatozoa remains to be shown. VD status in humans is generally monitored by measuring serum 25-hydroxyvitamin D levels, and there is a high frequency of VD insufficiency (,50 nM) among otherwise healthy adults in the western world (Holick and Chen, 2008) . We hypothesized that VD deficiency in humans could aggravate semen quality as it does in rodents. Here, we show a positive association between VD serum level and sperm motility, and a direct effect of 1,25(OH) 2 D 3 on intracellular calcium concentration [Ca 2+ ] i , motility and acrosome reaction in mature spermatozoa.
Materials and Methods

Cross-sectional association study
From an ongoing monitoring study of semen quality of young men from the general Danish population (Jørgensen et al., 2010a,b) , 308 men participating January to December 2007 were retrospectively investigated for an association between serum VD levels and semen quality. Eight were excluded due to use of anabolic steroids (n ¼ 3), failure to deliver a semen sample (n ¼ 2), obstructive azoospermia (n ¼ 1), lack of blood sampling (n ¼ 1) and Gilbert Meulengracht disease (n ¼ 1), leaving 300 men in the study. The men delivered one semen sample, one blood sample (stored at 2208C until analysis), had a physical examination performed and answered a comprehensive questionnaire. The questionnaire included information on age, previous or current diseases, any known history of fertility, medication, etc. Internal standard (300 ml) was added to serum, control or calibrator (300 ml), and vortex-mixed for 2 min with 1 ml n-heptane. After mixing, the heptane phase was transferred to a heating block, and evaporated to dryness at 758C under a stream of nitrogen. The residue was dissolved in 300 ml MeOH: H2O (80:20) , and applied to the LC-MS/MS instrument (sample vol. 50 ml). and 180 nmol/l, respectively, and for 25-OH VD 2 were 7.6 and 4.6% at 43 and 150 nmol/l, respectively. Serum FSH levels were determined using a time-resolved immunofluorometric assay (Delfia; Wallac, Turku, Finland) and Inhibin-B by a specific two-sided enzyme linked immunoassay (Bio-Innovation Ltd, Oxford, UK). The intra-and inter-assay variation for measurements of FSH and Inhibin B were 3 and 4.5%, 15 and 18%, respectively. Furthermore, S-albumin (CV 1.8%), S-Calcium (CV 1.2%), and S-Alkaline Phosphatase (CV 1.3%) were measured on Cobas c501, and S-Parathyroid hormone (PTH) (CV 3.4%) on Cobas e601. All procedures performed as recommended by the manufacturer (Roche). Albumin-corrected calcium was calculated (Total S-calcium + (0.0166 × (39,9 g/l 2 S-albumin (g/l)). All serum assessments were done at the same time to reduce the influence of inter-assay variation.
Assessment of VD, reproductive hormones and other biochemical variables
Semen analysis
The participants produced a semen sample by masturbation. Self-reported information of duration of ejaculation abstinence was obtained. Trained technicians conducted semen analysis and a detailed description of assessment of semen samples has previously been published (Jørgensen et al., 2001 (Jørgensen et al., , 2002 . Semen volume was estimated by weighing. For sperm motility assessment, duplicates of 10 ml of well-mixed semen were placed on a glass slide, examined on a heating stage kept at 378C, under a microscope at ×400 magnification, and spermatozoa were classified as progressive motile (WHO class A+B), non-progressive motile (class C) or immotile (class D). The average of the two motility assessments was used. For the assessment of the sperm concentration the samples were diluted in a solution of 0.6 mol/l NaHCO 3 and 0.4% (v/v) formaldehyde in distilled water, and subsequently assessed using Bürker-Türk hemocytometer. Only spermatozoa with tails were counted (Jørgensen et al., 2001 (Jørgensen et al., , 2002 . Finally, smears were prepared, Papanicolaou stained and spermatozoa morphology assessed according to strict criteria (Menkveld et al., 1990) .
Semen samples for in vitro studies
Semen samples for the in vitro studies were obtained from 40 men from the general population, who were investigated between October 2009 and December 2010. Their semen samples were assessed as described above. To investigate the effect of VD on sperm motility, the semen samples were exposed to 1 nM 1,25(OH) 2 D 3 for 45 min and motility scored as described earlier. Motility assessment was conducted in 17 samples (in duplicates) under non-capacitating conditions (in their seminal plasma), and 3 samples were also analyzed in capacitating conditions. Seven consecutively included men were used to investigate a dose -response relationship between VD and sperm motility.
Calcium measurements and the acrosome reaction were performed on motile spermatozoa isolated after percoll density gradient centrifugation (Supra sperm gradients, (ORIGO)) following the manufacturer's instructions. Briefly, spermatozoa were separated from seminal plasma by centrifugation on a discontinuous percoll gradient using a two-step gradient comprising 2 ml layers of 55 and 80% percoll respectively. Semen was placed on the top of the gradient and centrifuged at 300g for 25 min. The spermatozoa at the base of the 80% fraction were collected and washed with a 5 ml volume of capacitating medium (CaCl 2 1,5 mM, KCl 4.3 mM, NaHCO 3 31 mM, HEPES 15 mM, Human Serum Albumin 5 mg/ml, Glucose 4.5 mM, Sodium Pyruvate 0.8 mM, Synthetic Serum Replacement, 0.5 ug/ml human recombinant insulin (Sperm preparation media (ORIGO)) and finally resuspended in capacitating media and used for the following assays of calcium measurements and acrosome reaction. All men were part of the above mentioned ongoing surveillance program of semen quality among young Danish men and included after approval from the local ethical committee (No. H-4-2010-016 ).
Effect of VD on calcium levels in human spermatozoa
Semen samples were separated by percoll density gradient centrifugation to ensure viable and motile spermatozoa and resuspended in capacitating media for 1.5 h. Afterwards, loaded with 3 mM of the fluorescent probe (intracellular calcium binding) fura-2/AM (Invitrogen, USA) for 30 min, centrifuged (10 min at 300 g) and washed with Krebs -Ringer buffer (120 mM NaCl, 15 mM NaHCO 3 , 5 mM KCl, 1 mM CaCl 2 , 5 mM Na 2 HPO 4 , 1 mM MgCl 2 pH 7.3). In a Ca-free Krebs -Ringer solution CaCl 2 was substituted for 5 mM EGTA (calcium-free with EGTA). Subsequently, 80 ml of the sperm sample was diluted in 920 ml KrebsRinger buffer and loaded on polylysine-coated chambers to minimize movement of the spermatozoa (Lab-Tek; Nalge Nunc International, USA). A Zeiss Axiovert 135 microscope equipped with a Zeiss Achrostigmat 40 × 1.3 NA objective was used to acquire images from the fluorescent probe. Excitation was obtained by a Polychrome Villuminator from Till Photonics (Germany) and images were acquired using a Cool Snap CCD camera (Photometrics, USA) from Robert Scientific (Malaysia). For measurements of [Ca 2+ ] i , the excitation wavelengths were 338 and 380 nm, measuring emission above 510 nm using a cutoff filter. Calculations of [Ca 2+ ] i were conducted by MetaFluor software from Molecular Devices and using a K d of 160 nM (Gromada et al., 1996) . After background subtraction, ratio images were formed using MetaFluor software. Chemicals, 1a,25(OH) 2 D 3 (1,25(OH) 2 D 3 ), 25-OH D 3 , progesterone, thapsigargin, nifedipine and ionomycin were purchased from Sigma-Aldrich (USA), PL were carried out in triplicates C-inhibitor U73122
The non-genomic VDR antagonist 1b,25-(OH) 2 D 3 was a gift from LEO Pharma (Denmark). All experiments started by using low magnification to ensure visibility of several spermatozoa simultaneously. When a color change was observed in most cells, higher magnification was used. All measurements of [Ca 2+ ] i were based upon evaluation of at least three spermatozoa simultaneously (see exact number in figure legends), and were repeated in at least three separate experiments. We used 10 different semen donors to ensure that all experiments were reproduced on semen samples from at least two different men.
Acrosome reaction
Acrosome status was assessed according to a modified version of the method described by Cross et al. (1986) . Motile spermatozoa were isolated by percoll gradient centrifugation, washed twice with 5 ml 0.9% sodium chloride followed by centrifugation at 300g for 10 min. Hereafter, the motile spermatozoa were resuspended with or without 1 nM 1,25(OH) 2 D 3 for 1.5 h at room temperature in 0.9% sodium chloride or resuspended in capacitating media for 1.5 h at 378C and 5% CO 2 before the sperm was smeared on a glass slide and a cytospin was created. The smear and cytospin were fixed in 96% ethanol for 5 min after air drying, washed in distilled water and stained for minimum 2 h with Pisum sativum agglutinin labeled with fluorescein isothiocyanate (Sigma-Aldrich) in Dulbecco phosphate buffered saline at 48C. Finally, the slides were washed in distilled water and mounted with Vectrashield (H-1080 Vectar Laboratories) and 200 spermatozoa were counted on each slide using a fluorescence microscope at a magnification of 400×. The mean percentage of acrosome-reacted spermatozoa of the two slides was calculated. When more than half the head of a spermatozoon was brightly and uniformly fluorescent, the acrosome was considered to be intact. Spermatozoa without fluorescence or with a fluorescing band limited to the equatorial segment were considered to be acrosomereacted. Spermatozoa with a fluorescing band limited to the equatorial segment were named eq-AR. The person assessing the slides was blinded to the treatment of the sample.
Statistics
The cross-sectional cohort of 300 men were stratified according to their 25(OH)D 2+3 (25-OH-VD) serum level: ,25 nmol/l (deficient), 25 -50 nmol/l (insufficient), 50 -75 nmol/l (sufficient) and .75 nmol/l (high). For a basic description median and 5-95 percentiles were used.
Between-group differences were tested by the non-parametric KruskalWallis test. Correlations between 25-OH-VD (as a categorical variable) and both semen variables and reproductive hormone levels were examined using the non-parametric Spearman's rank test. To test for the effect of 25-OH-VD regression analyses were also performed. 25-OH-VD categories were first entered as a covariate in models having the semen variables or the reproductive hormones as dependent variables. Secondly, 25-OH-VD and 25-OH-VD-squared entered the model as continuous variables. In all regression models, semen volume, sperm concentration, total sperm count, FSH and Inhibin-B were natural logarithm transformed and motility variables logit transformed before analysis to obtain normal distribution of the residuals. The following covariates were tested: duration of ejaculation abstinence, hour-of-day of blood sampling, smoking, BMI, age, medication, fever, time from ejaculation to motility assessment, morphology observer, history of cryptorchidism, birthweight, season, albumin-corrected calcium, covariates with a significance level of 15% or below were included as stated for each analysis in Table I . The results from the in vitro studies were tested using paired t-test (two-tailed). For all analyses, P , 0.05 was considered statistically significant. Analyses were performed using PASW GradPack 18.0 (SPSS Inc., Chicago, IL, USA).
Results
Cross-sectional association study Table I summarizes the basic characteristics of the study subjects and Table II their semen variables, reproductive hormones, VD and other serum variables. The men were examined throughout the year, and median 25-OH-VD-levels differed according to season: 52 nM in spring (March-May, 31%), 66 nM in summer (June -August, 23%), 53 nM in autumn (September -November, 26%) and 34 nM in winter (December -February, 20%). The levels were significantly Vitamin D is positively associated with sperm motility lower during winter compared with spring (P , 0.0005), summer (P , 0.003) and autumn (P , 0.003). Correlation coefficients were positive between serum 25-OH-VD and all semen variables and Inhibin-B, although only significantly correlated for progressive motility and total motility (AB Motility: R ¼ 0.134, P ¼ 0.021; ABC Motility: R ¼ 0.114, P ¼ 0.049; Table II Figure 1 shows motility, progressive motility and morphology levels according to four categories of serum 25-OH-VD levels. For all three semen variables the between-group differences were only significant when comparing the highest versus the lowest 25-OH-VD as shown in Fig. 1 . Adjustment for relevant confounders (Semen volume: duration of abstinence, season and medication; Total sperm number: duration of abstinence, fever, season and medication; Sperm concentration: duration of abstinence, alb.cor. calcium and fever; Motility and Progressive motility: time from ejaculation to motility assessment and alb.corr. calcium; Morphology: duration of abstinence and season; FSH, albumin and alb.cor. calcium: BMI; Inhibin B, calcium and alkaline phosphatase: none) did not change the results markedly for sperm motility, progressive motility or morphology, but the significance level increased for motility (ABC: P ¼ 0.025, AB: P ¼ 0.020) and morphology being borderline significant (P ¼ 0.060). When 25-OH-VD entered the regression model as a continuous squared term the associations remained positive, and was reinforced with lower P-values (ABC: P ¼ 0.026, AB: P ¼ 0.023), whereas the significance level for morphology increased to P ¼ 0.109 (Supplementary data, Fig. S1 ). Regression analyses did not show any associations between 25-OH-VD and semen volume, total sperm concentration, total sperm count, Inhibin-B or FSH, height, weight, BMI and testis size neither when entered as a categorical or a continuous variable.
VD and intracellular calcium in human spermatozoa
Addition of 1,25(OH) 2 D 3 (100 pM -10 mM) to the motile spermatozoa induced a rapid increase in intracellular calcium concentration ([Ca 2+ ] i ) ( Fig. 2A -C and Supplementary data, Video S1). The increase was 5-10-fold from baseline calcium level and started within 5 s in the neck region and propagated up in the post-acrosomal region and down through the proximal midpiece ( Fig. 2A -C) . This effect was reproducible from 100 pM, and the threshold for the observed all-or-nothing response was between 10 -50 pM 1,25(OH) 2 D 3 (Fig. 2C) restored back to baseline concentration (Fig. 2C) . The amplitude did not increase with higher 1,25(OH) 2 D 3 concentrations, but the duration of the plateau phase was longer (50 -300 s). The maximum amplitude (max amplitude) of the calcium increase induced by 1 nM 1,25(OH) 2 D 3 varied between the investigated men. It was 5 -10-fold higher than baseline calcium level and 40-80% of the max amplitude elicited by 10 mM progesterone (Supplementary data, Fig.  S2 ). The effect of progesterone could not be abrogated by pretreatment with 1,25(OH) 2 D 3 (Fig. 2C ). The nuclear VDR antagonist (ZK159222, 0.1 -100 mM) was unable to abrogate or suppress the effect of 1,25(OH) 2 D 3 treatment (data not shown), but the VD response was blocked completely by pretreatment with 1 -40 mM of the non-genomic VDR antagonist 1b,25(OH) 2 D 3 (Fig. 2D) . Pretreatment with nifedipine 10 mM did not affect the response to 1,25(OH) 2 D 3 . The increase in [Ca 2+ ] i was initiated rapidly with a Vitamin D is positively associated with sperm motility maximum amplitude 7-fold higher than baseline, which was followed by 4 min long repolarization phase. However, nifedipine treatment caused an aberrant response to progesterone. The rapid initiation and steep increase in calcium seemed unaffected, but the plateau phase was terminated rapidly by a slow repolarization phase, and the calcium level was restored to baseline level 9 min after initiation of progesterone treatment (Figs 2C, D, 3A and Supplementary data, Fig. S2 ). Treatment with thapsigargin 4 mM caused a slow increase in baseline [Ca 2+ ] i in all spermatozoa (Fig. 3B) . Nine minutes after thapsigargin exposure it reached a stable plateau 3-fold higher than baseline calcium concentration. Addition of 1,25(OH) 2 D 3 (9 min after initiation of thapsigargin treatment) to these spermatozoa was unable to elicit a substantial calcium response, while lower concentrations of thapsigargin (,1 mM) were unable to abrogate the effect of 1,25(OH) 2 D 3 .
To test the mechanism downstream to the VDR, we used a phospholipase C (PLC) inhibitor U73122, to investigate whether VDR signaling was mediated by a PLC-dependent IP3 production, which may induce an intracellular calcium release. After exposure to 10 mM U73122, the majority (.80%) of the spermatozoa increased their baseline [Ca 2+ ] I more than 5-fold, most were immotile and were unresponsive to treatment with VD. To avoid bias from dying spermatozoa, we changed the concentration of U73122 to 2 mM, where most of the spermatozoa remained low and did not fluctuate in [Ca 2+ ] I and were motile. 1,25(OH) 2 D 3 was unable to induce a rapid increase in [Ca 2+ ] i in spermatozoa exposed to 2 mM U73122.
The increase in [Ca 2+ ] i was instead very slow with long-lasting (several minutes) increase unlike the normal rapid response, where the max amplitude was achieved within 1 min. The maximum amplitude was also lower, while the plateau phase was longer caused by a delayed repolarization (Fig. 3C) . PLC inhibition was unable to abrogate the effect of progesterone (data not shown). We observed a marked response to 1,25(OH) 2 D 3 in a calcium-free media ([Ca 2+ ]
,5 mM) without EGTA (Fig. 3D) . (Fig. 3E) . Ionomycin (500 nM) induced a low but reproducible increase in [Ca 2+ ] i in the calcium-free media with EGTA (Fig. 3E ).
The amplitude of the response to ionomycin was low (,3-fold from baseline), indicating that the intracellular Ca 2+ stores could be although the plateau phase was longer in the spermatozoa exposed initially to a calcium-free media (Fig. 3F) . 25-OH D 3 (100 nM) was unable to elicit an increase in [Ca 2+ ] i . Resuspending the motile spermatozoa in non-capacitating media resulted in a lower amplitude to Vitamin D is positively associated with sperm motility 1 nM 1,25(OH) 2 D 3 treatment, but a comparable response pattern to the effects observed in capacitating media (data not shown). In both media few spermatozoa were unresponsive to 1,25(OH) 2 D 3 treatments.
VD induces sperm motility and the acrosome reaction in vitro
We investigated a dose-response relationship between 1,25(OH) 2 D 3 and the induction sperm motility (ABC motility). We tested the effect of 1,25(OH) 2 D 3 in the concentration range from 10 215 to 10 23 M and found a non-linear dose-response relationship. We found a modest increase in median sperm motility between 2 and 7% in the concentration range from 10 214 to 10 29 M (Fig. 4A) . The concentration range from 10 212 to 10 29 M induced the highest increase in motility, and the strongest induction was found for 10 29 M with a median increase of 7% (P ¼ 0.006). Concentrations above 10 27 M resulted in a decreased motility compared with control (10 25 M, median 15% decrease). We extended this by studying semen samples from 17 men with and without exposure to 10 29 M 1,25(OH) 2 D 3 for 30 min at room temperature between 1 and 3 h after ejaculation. Their mean sperm motility increased significantly (P ¼ 0.010) after VD exposure with 2.9%, 95% CI [1%;5%]. Most men had a modest increase in sperm motility although a subset (n ¼ 3) of the men had a slight decrease in motility (Fig. 4B) . 1,25(OH) 2 D 3 (10 29 M) significantly (P ¼ 0.024) increased the number of acrosome-reacted spermatozoa with an average increase of 6%, 95% CI [1%;10%] (median, control group 12% and VD group 21%), while the percentage of spermatozoa with an equatorial band (eq.AR) increased from a median of 4.7 -5.3% (P ¼ 0.214; Fig. 4C ). Six men were investigated in non-capacitating conditions (NaCl), and there was no significant difference between VD treated and the control group (4.2 versus 3.7%).
Discussion
The positive association between VD serum level and sperm motility supports the observed in vitro effects of activated VD, and indicates that VD may have a role in human sperm function. The associations to sperm motility and progressive motility were modest, but significant and were best described using a squared term, indicating that the potential effect of VD is probably most pronounced in men with VD deficiency as suggested in the animal deficiency models (Kwiecinski et al., 1989; Uhland et al., 1992) . Calcium alone restored the fertility potential in VD deficient rodents (Uhland et al., 1992) and calcium was positively associated with sperm motility, so we tried to separate the effect of VD and calcium by controlling for calcium in the regression analyses. The associations to sperm motility were strengthened, indicating a direct effect of VD on human spermatozoa. Serum VD level has a relatively short half-life and is primarily influenced by the magnitude and duration of UV-B radiation . To oppose bias, the cohort was recruited throughout the year in different seasons with variable sun exposure (Lips, 2006) . Forty-four percent of our healthy young men had VD levels below 50 nM, comparable with previous studies conducted on healthy Danes from the general population, indicating that this cohort appear representative for young Danish men (Mosekilde et al., 2005; Frost et al., 2010; Hey, 2010) . Other potential confounders besides calcium such as, BMI, weight, season, birthweight, fever, medication, duration of abstinence, time from ejaculation to motility assessment, morphology observer, medication, smoking and history of genital disease were accounted for in the statistical analyses, and none of these factors explained our findings. A recent study reported on a positive association between VD serum levels and sperm motility, but it was only borderline significant (Ramlau-Hansen et al., 2011) . However, this study had some limitations, primarily caused by few men with VD insufficiency or VD deficiency in the cohort. Furthermore, they stratified the men in tertiles rather than dividing them according to clinical relevant VD status groups. Therefore, men in the lowest tertile had VD serum levels ranging from 8 to 62 nM (only 6% having ,25 nM), so they compared men with mild VD insufficiency with men having a higher level of VD and found only a borderline statistically significant correlation. In addition, they adjusted sperm motility for eight different confounders (not including calcium) without reporting the significance level for any of covariates. Thus, there is no discrepancy between these recently published findings and ours, and we believe that these results are supportive for a weak positive association between VD serum levels and sperm motility, although the strongest associations are found in men with VD insufficiency or deficiency.
The lower number of motile, especially progressive motile and morphologically normal spermatozoa in VD deficient men are not of clinical importance in men with a normal spermatogenic function. However, it could be an important reversible factor, if these findings also holds true in infertile men, because VD supplements alone was able to restore semen quality in VD deficient rodents (Kwiecinski et al., 1989) . Male infertility in humans is a heterogeneous disease, and one may argue that VD is not an etiological factor, but instead a marker of general health (Skakkebaek et al., 1994) . On the other hand, our in vitro data showed direct effects of VD in mature spermatozoa, which is supported by the testicular histology in one of the VDR KO mice; characterized by several atrophic tubules and few tubules with complete spermatogenesis, and that normalization of serum calcium alone cannot normalize testis histology (Kinuta et al., 2000) . Moreover, mice with induced cryptorchidism improved histology (Johnson score) after treatment with activated VD (Hirai et al., 2009) . We found no association between VD serum level and total sperm number in our cohort. This was supported by comparable levels of Inhibin-B and FSH in all VD groups and in accordance with the results published recently (Ramlau-Hansen et al., 2011; Jorgensen et al., 2010a) . However, VD deficient and VDR KO mice have low sperm number (Uhland et al., 1992; Sood et al., 1995) , and the lack of an association between VD serum levels and sperm production in the human studies could be influenced by several factors: long duration of human spermatogenesis (70 -80 days), short VD half-life in serum and serum calcium level. VD deficient rodents develop hypocalcemia and their sperm counts could be restored by calcium supplements alone (Uhland et al., 1992; Kinuta et al., 2000) .
Presence of VDR and the VD metabolizing enzymes in the neck of mature spermatozoa indicates that VD may have a function in the female reproductive tract. The concentration of VD progenitors in both female and male reproductive tract has to our knowledge not been shown, although the concentration of 1,25(OH) 2 D 3 in the follicular fluid during in vitro fertilization has been measured and suggested to be cyclic with the highest concentration at ovulation (Potashnik et al., 1992) . VD is metabolized locally in the male reproductive tract, and the concentrations of 1,25(OH) 2 D 3 that induced an effect in the in vitro studies are close to the physiological concentrations in serum (≈1 × 10 210 M), other somatic tissues, and to the dissociation constant for VDR ≈1- initiated within seconds and is presumably a non-genomic effect (Ho and Suarez, 2003) . Spermatozoa are transcriptionally silent and a non- Vitamin D is positively associated with sperm motility genomic effect of 1,25(OH) 2 D 3 was confirmed by using the nongenomic VDR antagonist 1b,25(OH) 2 D 3 , which abrogated the response to 1,25(OH) 2 D 3 completely (Norman et al., 2004; Galeraud-Denis et al., 2007) . The effects downstream to the VDR were elucidated by showing that nifedipine was unable to affect the VD response, unlike the progesterone response, in which the plateau phase was terminated rapidly by inhibition of the voltage-gated L-type calcium channel in accordance with an earlier publication (Kirkman-Brown et al., 2003) . The VD-mediated calcium release from an intracellular calcium storage was supported by showing that thapsigargin diminished the effect of 1,25(OH) 2 D 3 , although there exist some controversy regarding the concentrations needed to block the SERCA pumps in human spermatozoa (Bedu-Addo et al., 2008) . Naaby-Hansen el al. (2001) demonstrated by double staining that the calcium-binding protein calreticulin reside in the neck of human spermatozoa where it co-localize with the 1,4,5-trisphosphate receptor (IP 3 R), and this putative calcium storage has been suggested to be important during capacitation (Ho and Suarez, 2003) . We have previously shown that the VDR and all the VD metabolizing enzymes are expressed at the neck of human spermatozoa (Blomberg Jensen et al., 2010) , and since 1,25(OH) 2 D 3 is a known non-genomic inducer of PLC in other mesenchymal derived tissues, we investigated whether PLC inhibition was able to abrogate the calcium release induced by 1,25(OH) 2 D 3 (Civitelli et al., 1990) . The PLC-inhibitor U73122 caused a delayed and diminished response to 1,25(OH) 2 D 3 indicating that activated VDR may signal partly through PLC activation and hence increase IP 3 , which through activation of IP 3 R-gated calcium channels in RNE releases calcium from an intracellular storage (Ho and Suarez, 2003; Suarez, 2008) . To validate the calcium release from intracellular stores, we investigated the response to VD and progesterone in a calcium-free media without EGTA. 1,25(OH) 2 D 3 increased [Ca 2+ ] i rapidly, indicating that the calcium increase originated from intracellular stores. We also noticed that the phase of repolarization was aberrant resulting in an extended plateau phase, and we suggest that spermatozoa may have a calcium sensing receptor that record changes in extracellular calcium concentration. When using a Ca-free Krebs-Ringer solution with a low EGTA concentration, we noticed that the effect of both 1,25(OH) 2 D 3 and progesterone was abrogated, and ionomycin elicited only a small Ca 2+ rise when added to the solution. It has previously been suggested that the IP 3 -gated calcium storage in the RNE can be rapidly depleted by EGTA. This may explain the low amplitude induced by ionomycin in the calcium-free media, which ultimately could be caused by calcium release from other compartments, such as mitochondria (Norman, 1998; Jimenez-Gonzalez et al., 2006; Publicover et al., 2007; Costello et al., 2009) . The VD-induced calcium increase in human spermatozoa indicates that VD may be involved in the induction of motility, which is supported by the cross-sectional study, the animal models and the proposed function of the calcium storage in the neck of human spermatozoa (Bedu-Addo et al., 2008) . A role for hyperactivation remains to be shown, but 1,25(OH) 2 D 3 was able to induce a modest increase in sperm motility, which is in accordance with a previous study showing that VD increased calcium on sperm lysates, induced motility and increased acrosin activy (Aquila et al., 2009) . We found that 1,25(OH) 2 D 3 induced a significant higher proportion of motile spermatozoa to undergo the acrosome reaction (under capacitating conditions), which may be caused by propagation of the calcium increase from the neck to the head of the spermatozoa.
In conclusion, we show here that the positive association between VD serum levels and sperm motility is supported by novel functional findings, which indicate that VD may contribute to optimal sperm function. VDR and the VD metabolizing enzymes are expressed in mature spermatozoa, and in vitro experiments revealed that VD through non-genomic VDR activation increased intracellular calcium from an intracellular calcium storage in the neck of human spermatozoa, induced sperm motility and the acrosome reaction. Further studies are warranted to investigate the role of VD in spermatozoa from infertile men.
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